COVID-19 Breaking News
-
Akston Biosciences, Seppic Ink Commercial Supply Agreement
07.29.21
Deal is for an adjuvant to formulate shelf-stable COVID-19 vaccine at global scale.
-
Batavia to Develop Clinical Process for RocketVax’s COVID-19 Vaccine
07.08.21
After successful completion, Batavia will continue to scale-up and optimize the process for commercial scale.
-
Swiss Government Turns to Swissfillon for COVID-19 Test Kit Production
07.08.21
Drug product CMO specialist adapts to provide 0.8 million prefilled syringes.
-
The Power and Promise of Decentralized Trials
Derk Arts, CEO, Castor || 06.25.21
Clinical researchers turned to a range of digital solutions to address the effects of the COVID-19 pandemic on trials.
-
AbCellera to Build Antibody Manufacturing Facility in Canada
06.23.21
130,000-square-foot Vancouver facility aims to accelerate the development of antibody-based therapies for an array of medical conditions.
-
Maintaining Critical Drug Supply During the Pandemic
Tim Wright, Editor, Contract Pharma || 06.17.21
Vin Colicchio from Dr. Reddy’s talks about the challenges and solutions of maintaining supply during the pandemic.
-
Ocugen, Jubilant Enter COVID-19 Vaccine Partnership
06.15.21
Jubilant HollisterStier to manufacture COVAXIN for the U.S. and Canadian markets.
-
BD Hits 2 Billion Injection Device Milestone for COVID-19 Vaccinations
06.11.21
Company now supplying more than 40 countries for pandemic vaccination campaigns.
-
AGC Biologics Inks Supply Deal for COVID-19 Vaccine
Tim Wright, Editor, Contract Pharma || 06.07.21
CDMO’s Heidelberg facility to supply plasmid DNA for Pfizer/BioNTech COVID-19 vaccine.
-
Waking from the “Coma of COVID-19”
Emil W. Ciurczak, DoraMaxx Consulting || 06.07.21
What should the “New Normal” look like?
-
Waving Goodbye to Human Clinical Trials in a Post-COVID Landscape
Jaleel Shujath and Rao Mukkavilli, Absorption Systems || 06.07.21
Exploring the untapped potential presented by current biowaiver regulations.
-
Exelead Helps Manufacture Pfizer-BioNTech COVID-19 Vaccine
Tim Wright, Editor, Contract Pharma || 06.07.21
Pharmaceutical development and manufacturing company delivers first vaccine batch to Pfizer.
-
CPL Completes Successful Virtual Health Canada Audit
Tim Wright, Editor, Contract Pharma || 06.03.21
The CDMO created a virtual tour of its facilities in response to the pandemic.
-
Samsung Biologics Expands Vaccine Manufacturing Capabilities
Tim Wright, Editor, Contract Pharma || 06.01.21
To add mRNA vaccine drug substance manufacturing suite to expand portfolio of services.
-
Resilience Bolsters Canadian Biomanufacturing Site
Tim Wright, Editor, Contract Pharma || 05.21.21
Receives $164 million investment from the Government of Canada to modernize and expand Ontario site.
-
Humanigen Selects Chime Biologics as Manufacturing Partner
Tim Wright, Editor, Contract Pharma || 05.17.21
Ink manufacturing deal for COVID-19 therapeutic candidate lenzilumab.
-
FDA Expands EUA for Pfizer, BioNTech’s Covid-19 Vax
Charles Sternberg, Assistant Editor || 05.11.21
Expands the authorization to include individuals 12-15 years of age.
-
Implications of COVID-19 on Statistical Design and Analyses of Clinical Studies
Tim Victor, Head of Biostatistics, Clinical Research Services, ICON plc || 05.05.21
A look at the challenges and risks to statistical integrity and how they can be mitigated.
-
Moderna to Increase Global Supply for COVID-19 Vaccine
Tim Wright, Editor, Contract Pharma || 05.03.21
Will supply up to 3 billion doses in 2022 and double supply from ex-U.S. supply chain.
-
Sanofi, Moderna Enter COVID-19 Vaccine Fill/Finish Manufacturing Deal
Tim Wright, Editor, Contract Pharma || 05.03.21
Sanofi will provide fill/finish services for up to 200 million doses of Moderna’s COVID-19 vaccine in the U.S. beginning in September 2021.
